Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.49
-0.05 (-0.90%)
At close: Oct 21, 2025, 4:00 PM EDT
5.43
-0.06 (-1.07%)
After-hours: Oct 21, 2025, 7:59 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $301.37 million as of October 21, 2025. Its market cap has increased by 39.99% in one year.
Market Cap
301.37M
Enterprise Value
209.03M
1-Year Change
39.99%
Ranking
Category
Stock Price
$5.49
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $301.37M, an increase of 35.52%. That is a compound annual growth rate of 7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 304.12M | -17.51% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.89B |
| Johnson & Johnson | 463.51B |
| AbbVie | 408.00B |
| UnitedHealth Group | 332.64B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 223.68B |